Breast Implants Lymphoma Cancer

In a rush? You can use our Quick Contact Form to tell us the basic information about your case.

The Law Offices of Thomas J. Lamb represents people who have been harmed by unsafe medical products, including cases involving breast implants associated with lymphoma.

In more detail, the US Food and Drug Administration (FDA) has received reports about women who have had breast implant procedures done and, later, were diagnosed with these medical conditions:

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
Anaplastic Large Cell Lymphoma (ALCL)
Non-Hodgkin Lymphoma (also known as Non-Hodgkin’s Lymphoma, NHL, or just Lymphoma)
T-cell Lymphoma

Free Case Evaluation

We encourage you to submit a Breast Implants Cancer Case Review – it is free, confidential, and there is no obligation. Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible breast implants case. Either way, you will get Mr. Lamb’s impressions — not an intake person, a paralegal, nor some other lawyer — about your case based on his many years of experience.

More Information

Summary of Information
The Disease
FDA Information
Resources
Frequently Asked Questions
➤ About the Disease
➤ Symptoms
➤ Risk Factors
➤ Treatment
➤ Prognosis

About Us

We are here to help the women and families who have experienced this unfortunate situation. We have successfully handled personal injury and wrongful death cases for people throughout the country.

Our firm does not put its clients into large class actions lawsuits. Rather, an individual lawsuit is filed for each case. There are no costs associated with having us review your possible breast implants case.

Be assured that the information you provide to our law firm is treated as strictly confidential. Submitting a case evaluation does not obligate you to hire our law firm.

Lastly, we want you to know that you will get a reply directly from attorney Tom Lamb no later than the next business day.

Most Recent Article on This Topic

BIA-ALCL Case Studies Confirm Importance of Proper Treatment

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare cancer of the immune system. BIA-ALCL has been closely linked with textured surface breast implants.

What Causes BIA-ALCL?

While BIA-ALCL is rare, it is very serious and potentially fatal if not treated properly. According to December 2020 article, “Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research“, the U.S. currently has a lifetime risk of about 1 per 30,000 women with textured implants. The article gives several proposed triggers for the disease:

Proposed triggers for the development of malignancy include mechanical friction, silicone implant shell particulates, silicone leachables, and bacteria. Of these, the bacterial hypothesis has received significant attention, supported by a plausible biologic model.In addition, the guidance advises that patients should receive a decision checklist and information brochure highlighting the risks of BIA-ALCL, systemic symptoms, surgical risk, situations in which the devices should not be used, considerations for a successful implant candidate, and a discussion of options other than the breast implants.
FDA recommends that current estimated incidence rates of BIA-ALCL be included in the patient decision checklist, both overall figures and specific rates for the manufacturer’s product, based on published literature, registries and medical device reports. Manufacturers are told to explain in the checklist the methodology used in determining the incidence rates.
FDA updated rupture screening recommendations to follow the consensus advice of its expert panel for screening to begin between years five and six after surgery and then repeat every two to three years. Ultrasound was recommended as an acceptable alternative for screening asymptomatic patients.

The bacterial hypothesis is currently the most accepted and developed hypothesis for the cause of BIA-ALCL. In short, essentially a biofilm containing harmful bacteria forms on top of the implant, eliciting an inflammatory immune response. As a result, this causes a malignant transformation of cells resulting in BIA-ALCL.

To read more of this article, click below:

Implant Removal Case Studies

A study of 18 cases that involved implant removal and capsulectomy at the Memorial Sloan Kettering Cancer Center examined the relationship between the implants and BIA-ALCL. Out of the 18 cases, sixteen received the implants for reconstructive purposes after breast cancer. Additionally, two individuals received the implants for cosmetic reasons.

[Read article in full at original source]

Our earlier articles about this breast implants lymphoma cancer situation:

Breast Implants Cases Overview